Hybrid open and endovascular treatment of an aortic arch pseudoaneurysm in a patient with human immunodeficiency virus infection
Autor: | Chafik El Kettani, Y. Tijani, Mustapha Taberkant, H. Belmir, Nabil Maotassim Billah, Hassan Chtata |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Aortic arch
medicine.medical_specialty lcsh:Diseases of the circulatory (Cardiovascular) system medicine.medical_treatment Human immunodeficiency virus (HIV) lcsh:Surgery 030204 cardiovascular system & hematology medicine.disease_cause Endovascular aneurysm repair 030218 nuclear medicine & medical imaging 03 medical and health sciences Pseudoaneurysm Hybrid treatment 0302 clinical medicine Aortic arch pseudoaneurysm medicine.artery Case report medicine cardiovascular diseases Endovascular treatment Aorta business.industry Human immunodeficiency virus lcsh:RD1-811 Hybrid approach medicine.disease Thrombosis Surgery lcsh:RC666-701 cardiovascular system Cardiology and Cardiovascular Medicine business |
Zdroj: | Journal of Vascular Surgery Cases and Innovative Techniques, Vol 6, Iss 4, Pp 516-519 (2020) Journal of Vascular Surgery Cases and Innovative Techniques |
ISSN: | 2468-4287 |
Popis: | We describe an hybrid approach for aortic pseudoaneurysm with open and endovascular treatment as an alternative treatment for a high-risk patient infected with human immunodeficiency virus. A 42-year-old man, serum positive for human immunodeficiency virus, presented, with a large pseudoaneurysm of the arch aorta measuring 61 × 70 mm. An aortic arch debranching was performed, completed by thoracic endovascular aneurysm repair. A control computed tomography scan performed 3 months later showed a complete thrombosis of the pseudoaneurysm. The outcome of this treatment, particularly regarding the rate of infection, is yet to be determined, Longer follow-up is needed with a greater of patients. |
Databáze: | OpenAIRE |
Externí odkaz: |